• OPEN AN ACCOUNT
Indian Indices
Sensex
74,787.83 23.60
( 0.03%)
Global Indices
Nasdaq
52,403.42 -403.65
(-0.76%)
Dow Jones
7,657.83 -36.69
(-0.48%)
Hang Seng
65,056.24 -86.54
(-0.13%)
Nikkei 225
10,664.98 -146.68
(-1.36%)
Forex
USD-INR
94.74 0.23
(0.24%)
EUR-INR
110.11 0.28
(0.26%)
GBP-INR
128.27 0.39
(0.30%)
JPY-INR
0.62 0.01
(0.94%)

EQUITY - MARKET SCREENER

Vivimed Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532660
INE526G01021
-18.1148384
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VIVIMEDLAB
0
52.24
EPS(TTM)
Face Value()
Div & Yield %
0
2
0
 

Sundaram Finance consolidated net profit rises 0.22% in the March 2026 quarter
May 25,2026
Net profit of Sundaram Finance rose 0.22% to Rs 554.17 crore in the quarter ended March 2026 as against Rs 552.98 crore during the previous quarter ended March 2025. Sales rose 13.34% to Rs 2560.40 crore in the quarter ended March 2026 as against Rs 2259.05 crore during the previous quarter ended March 2025.

For the full year,net profit rose 9.55% to Rs 2058.86 crore in the year ended March 2026 as against Rs 1879.44 crore during the previous year ended March 2025. Sales rose 15.59% to Rs 9808.92 crore in the year ended March 2026 as against Rs 8485.63 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2560.402259.05 13 9808.928485.63 16
OPM %78.7683.70 -78.3380.35 -
PBDT848.62828.06 2 3001.852669.95 12
PBT781.63764.78 2 2756.182447.39 13
NP554.17552.98 0 2058.861879.44 10